Skip to content
Events

Details

Illumina will be hosting a Symposium: at the 10 Congresso Triennale di Anatomia Patalogica SIAPeC IAP (SIAPeC IAP)​ in Milan, Italy on the 3rd-6th December 2025. 

Focus tecnico: evoluzione dei pannelli e dei software di interpretazione​​

13:00 - Apertura lavori e introduzione​

13:05 - Profilazione genomica oncologica: l’esperienza del Policlinico Gemelli dal 2022 su oltre 6000 casi – Camilla Nero​

13:20 - Focus tecnico: evoluzione dei pannelli e dei software di interpretazione -   Angelo Minucci​

13:35 - Q&A: spazio alle domande​

13:50 - Chiusura lavori

 

Friday 5th December 13:00 – 14:00 in room Sala Polar

 

Date & Time
3 Dec 2025 – 6 Dec 2025
Location
Quark Hotel – Via Lampedusa, Milan (MI)
Italy
Europe
Topic
Oncology
Visit Website

Related Events

Nov 4
Illumina Innovation Days
4 Nov 2025 – 5 Dec 2025
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Nov 27
Convention UniCancer
27 Nov 2025
Illumina is sponsoring Convention UniCancer - we look forward to seeing you there.
View Event
Dec 1
Autumn meeting of the AG Molecular Pathology in 2025
1 Dec 2025 – 2 Dec 2025
Illumina will be exhibiting at the Autumn meeting of the AG Molecular Pathology in Rhein Sieg Forum in Siegburg, Germany on the 1st - 2nd 2025. Come and visit us at our booth, where you can meet our expert team to learn about our solutions and services on offer and discuss any requirements you may have. We will also be hosting a Symposium: TruSight Oncology 500 v2 – Ein neuer Standard für die umfassende genomische Analyse in der onkologischen Forschung
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.